Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 852Neoplasms 643Prostatic Neoplasms 439Lung Neoplasms 359Colorectal Neoplasms 327Carcinoma, Non-Small-Cell Lung 318Leukemia, Myeloid, Acute 251Pancreatic Neoplasms 218Brain Neoplasms 202Multiple Myeloma 198Neoplasm Metastasis 191Carcinoma, Hepatocellular 178Head and Neck Neoplasms 176Glioblastoma 167Precursor Cell Lymphoblastic Leukemia-Lymphoma 166Melanoma 153Ovarian Neoplasms 149Squamous Cell Carcinoma of Head and Neck 148Rectal Neoplasms 134Recurrence 132Hematologic Neoplasms 125Sarcoma 124Uterine Cervical Neoplasms 117Stomach Neoplasms 116Carcinoma, Renal Cell 115Triple Negative Breast Neoplasms 114Glioma 114Motor Activity 100Myelodysplastic Syndromes 96Esophageal Neoplasms 96

Interventions

N-monoacetylcystine 1Magnetoencephalography 1Inhalation 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Attention Deficit Disorder with Hyperactivity × 90 days × Clear all
NCT04481048 2026-06-05

DoDNAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
25 enrolled 12 charts
CNS

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1

NCT06668519 2026-03-25

Magnetoencephalography in Children

Children's Hospital of Fudan University

Recruiting
1,500 enrolled
CNS

Attention Deficit Disorder with Hyperactivity, Autistic Disorder, Brain Neoplasms, Cerebrovascular Disorders, Developmental Disabilities, Epilepsy, Intellectual Disability, Tic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡